ENDLOS-TURBO PUT - AMGEN | Market Closed - Boerse Frankfurt Warrants 20:35:08 03/06/2024 BST | ||
| 11.55 EUR | -3.35% |
|
| Current month | -2.18% | ||
| 1 month | -0.51% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 03/06/24 | 11.69 | -2.18% |
| 31/05/24 | 11.95 | -1.32% |
| 30/05/24 | 12.11 | -4.72% |
| 29/05/24 | 12.71 | +2.83% |
| 28/05/24 | 12.36 | +7.29% |
Real-time Boerse Frankfurt Warrants
Last update June 03, 2024 at 08:35 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ8BSQ |
| ISIN | DE000DJ8BSQ4 |
| Date issued | 10/01/2024 |
| Strike | 433 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 11.35 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.32 € |
|---|---|
| Lowest since issue | 10.08 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
307.4
USD
Average target price
316.3
USD
Spread / Average Target
+2.88%
- Stock Market
- Certificates
- Certificat